17301 studies found for:    ( NOT NOTEXT ) [FIRST-RECEIVED-RESULTS-DATE]
Show Display Options
RSS Create an RSS feed from your search for:
( NOT NOTEXT ) [FIRST-RECEIVED-RESULTS-DATE]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Interventions: Drug: abatacept;   Drug: cyclophosphamide;   Drug: azathioprine;   Drug: prednisone;   Drug: abatacept placebo;   Drug: azathioprine placebo
2 Completed
Has Results
An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment
Condition: Renal Impairment
Intervention: Drug: Deferiprone
3 Completed
Has Results
Image Quality and Radiation Dose in Angiography
Conditions: Arteriovenous Malformations;   Aneurysm;   Stenosis;   Dural Arteriovenous Malformations
Interventions: Radiation: Low dose DSA (75% reduction compared to normal dose) with novel X-ray imaging technology.;   Radiation: Normal dose DSA with conventional X-ray technology
4 Completed
Has Results
Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis
Conditions: Osteoporosis, Postmenopausal;   Back Pain;   Spinal Fracture
Interventions: Drug: teriparatide;   Drug: risedronate;   Drug: placebo
5 Completed
Has Results
Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis
Conditions: Continuous Ambulatory Peritoneal Dialysis;   End Stage Renal Disease
Intervention: Drug: ertapenem
6 Completed
Has Results
Natalizumab De-escalation With Interferon Beta-1b
Condition: Relapsing-remitting Multiple Sclerosis
Interventions: Drug: interferon beta-1b;   Drug: Natalizumab
7 Completed
Has Results
Safety and Efficacy of COV795 in Moderate to Severe Post-Operative Bunionectomy Pain With an Open-label Extension
Conditions: Pain, Postoperative;   Bunion
Interventions: Drug: COV795;   Drug: Placebo
8 Completed
Has Results
Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine Including a 12 Weeks Extension and an Open-label 48 Weeks Extension Study
Condition: Acute Gout
Interventions: Drug: Canakinumab 150 mg;   Drug: Triamcinolone acetonide 40 mg;   Drug: Placebo to canakinumab;   Drug: Placebo to triamcinolone acetonide
9 Completed
Has Results
A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Placebo
10 Completed
Has Results
Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.
Conditions: Pneumococcal Disease;   13-valent Pneumococcal Vaccine
Intervention: Biological: 13-valent Pneumococcal Conjugate Vaccine
11 Completed
Has Results
Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN®
Conditions: Glaucoma,Open-Angle;   Ocular Hypertension
Intervention: Other: Observational
12 Completed
Has Results
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: 500 mg LX1606 QD;   Drug: 500 mg LX1606 TID;   Drug: Placebo
13 Completed
Has Results
A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)
Conditions: Hypertension;   Metabolic Disorder
Intervention: Drug: losartan potassium (+) hydrochlorothiazide
14 Completed
Has Results
Pharmacogenomic Evaluation of Antihypertensive Responses 2
Condition: Hypertension
Interventions: Drug: Metoprolol;   Drug: Chlorthalidone
15 Completed
Has Results
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma;   Recurrent Ovarian Carcinoma
Intervention: Drug: Paclitaxel Albumin-Stabilized Nanoparticle Formulation
16 Completed
Has Results
A Research Study Examining The Use Of Duloxetine In The Prevention Of Migraine Headache
Condition: Migraine
Intervention: Drug: duloxetine
17 Active, not recruiting
Has Results
Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Letrozole;   Drug: Zoledronic acid
18 Completed
Has Results
Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected Patients
Condition: HIV Infections
Interventions: Drug: Nevirapine XR;   Drug: Nevirapine IR
19 Completed
Has Results
Safety and Efficacy of Combigan® Ophthalmic Solution in Korea
Conditions: Glaucoma, Open-Angle;   Ocular Hypertension
Intervention: Drug: brimonidine tartrate/timolol maleate Ophthalmic Solution
20 Terminated
Has Results
A Trial to Evaluate the Correlation Between Spontaneous Catch-up Growth, Clinical Response to Saizen (Recombinant Human Growth Hormone, r-hGH) and Gene Expression Profiling in Children Small for Gestational Age (SGA)
Condition: Infant, Small for Gestational Age
Intervention: Drug: Recombinant human growth hormone (r-hGH)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years